I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Pulmonary aspergillosis is an acute or chronic lung disease due to aspergillus infection and daily inhalation of aspergillus conidia. Clinically, it is classified into chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis, and invasive pulmonary aspergillosis (IPA). IPA is the most common subtype.\[[@ref1]\] The high IPA morbidity is observed in the immunocompromised patients under conditions such as the history of organ transplantation, the concurrence of malignant tumor and the history of receiving therapy with corticosteroids or immunosuppressant.\[[@ref2][@ref3]\] The early diagnosis of IPA is very difficult because of its nonspecific symptoms and rapid symptom progression. The mortality is high up to 80--95%.\[[@ref4]\]

Aspergillus infection induces natural immunity and acquired immunity. Innate immune cells such as alveolar macrophages (AMs) and neutrophilic granulocytes can internalize and kill the invading aspergillus conidia and inhibit conidia germinating into hyphae through oxidation and nonoxidation mechanisms.\[[@ref5]\] T cells play an important role in acquired immunity after aspergillus infection. Among immune competent patients, Th1 immune responses are predominantly induced. Th1 cytokines such as interleukin (IL)-12, interferon (IFN)-γ, tumor necrosis factor (TNF)-α can promote the differentiation of Th0 cells into Th1 cells, and eliminate aspergillus.\[[@ref6]\] However, in immune-compromised patients, AMs and neutrophilic granulocytes cannot kill hyphae and conidia effectively. After patients were infected, Th2 immune responses were predominantly induced and lead to imbalanced Th1 and Th2 responses.\[[@ref7]\] The increased Th2 cytokines such as IL-10 and IL-4 promoted the differentiation of Th0 cells into Th2 cells, and inhibited the immune response and facilitated aspergillus infection.\[[@ref6]\]

Dendritic cells (DCs) are the most powerful professional antigen-presenting cells, and responsible for antigen recognition and procession.\[[@ref8]\] They could initiate primary immune response and play an important role in host defense against pathogen infection and tumor progression. The pattern recognition receptors on DCs recognize pathogen-associated molecular patterns. Toll-like receptors (TLRs) can activate DCs by recognition of lipids, lipopolysaccharide, nucleic acid, etc.; whereas C-type lectin receptors (CLRs) can recognize the mannose-specific ligand on pathogen surface or glycoprotein of autoantigens.\[[@ref7][@ref9]\] TLRs and CLRs synergistically activate DCs to produce various pro-inflammatory, anti-inflammatory cytokines and reactive oxygen species.\[[@ref10]\]

DC-specific intercellular adhesion molecule-3-grabbing nonintegrin (SIGN), also called CD209, is a group II CLR,\[[@ref11]\] specifically expressed on the cell surface of DCs.\[[@ref12][@ref13]\] It has been reported that DC-SIGN participated in host defense against pathogen infection.\[[@ref7]\] In recent years, some studies have proved that DC-SIGN participated in the elimination of multiple pathogens such as human immunodeficiency virus, Ebola virus, mycobacterium tuberculosis, and fungi.\[[@ref7][@ref9]\] In immunocompetent patients with pulmonary aspergillosis, DC-SIGN could recognize the mannose domain on the cell wall of aspergillus conidia,\[[@ref7]\] then recruit TLRs\[[@ref14][@ref15][@ref16][@ref17]\] and lead to promote DC endocytosis and activation of nuclear factor (NF)-κB.\[[@ref16][@ref18]\] Currently, it is accepted that DC-SIGN recognizes aspergillus conidia and induces inflammation through TLR signaling pathway,\[[@ref14][@ref15]\] while Mitogen-activated protein kinases and NF-κB are activated in DCs and cause a panel of inflammatory cytokines release.\[[@ref18][@ref19][@ref20]\] However, in immunocompromised patients, DCs failed to engulf conidia via phagocytosis. After DCs recognize aspergillus conidia, they migrate through blood circulation into other tissues and cause aspergillosis. DCs secret more Th2 cytokines such as IL-4 and IL-10 instead of Th1 cytokines, which results in the imbalance of Th1 and Th2 immune response and antigen immune evasion. The underlying mechanism has not been elucidated yet. Does DC-SIGN participate in intracellular signaling activation or Th1/Th2 balance? What\'s the underlying molecular mechanism? Whether does DC-SIGN participate in aspergillus immune evasion? All these questions have not been elucidated. To answer these questions, this study performed the following experiments to elucidate the possible mechanisms via modulation of DC-SIGN expression in DCs after aspergillus infection.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

The study was approved by the Ethical Committee of Fundan University.

Generation of monocyte-derived dendritic cells and co-culture with stimuli {#sec2-2}
--------------------------------------------------------------------------

Peripheral blood mononuclear cells (PBMCs) were isolated from heparinized blood obtained from Zhongshan Hospital, Fudan University using Ficoll-Paque (Biowest, France) density gradient centrifugation and Lymphocyte Separation Medium (Biowest, France). The low-density PBMCs were cultured in Roswell Park Memorial Institute (RPMI) 1640 Medium at 37°C for 3 h to allow monocytes adherent, and then non-adherent cells were removed. For DCs, 2 × 10^6^ cells/ml monocytes were cultured in RPMI 1640 Medium with 10% fetal bovine serum (FBS) for 7 days in the presence of 50 ng/ml human recombinant granulocyte-macrophage-colony-stimulating factor (Prospec, Israel), and 20 ng/ml human rIL-4 (Peprotech, America). The DC cultures were received an additional dose of GM-CSF and IL-4 every other day.\[[@ref21]\]

On day 6, the cultured monocyte-derived DCs (MDDCs) were stimulated with 10^−4^ mol/ml dexamethasone (Dex; Shandong Xinhua Pharmaceutical Co., Ltd., China) for 24 h as Dex group. The 50 ng/ml IFN-γ (Peprotech, America) was added for 12 h as IFN-γ group. The 2 μg/ml Mannan was added for 24 h as Mannan group. The cultured cells were then stimulated with inactivated *Aspergillus fumigatus* (Af) (DC:Af = 1:10) for 24 h. Cells were labeled separately as control, IFN-γ, Dex, control/Af, IFN-γ/Af, Dex/Af, and Mannan/Af groups.

Preparation of inactivated *Aspergillus fumigatus* {#sec2-3}
--------------------------------------------------

Conidia of Af (ATCC 13073, an organism originally isolated from a patient with invasive aspergillosis) were harvested after 4 days of culture on Sabouraud dextrose agar (Difco, Detroit, USA), filtered through sterile gauze, killed by heating in a water bath at 100°C for 1 h, washed with saline solution, and stored at 4°C.

Cytokine assay {#sec2-4}
--------------

The level of IL-12 and IL-10 was determined using IL-12 and IL-10 ELISA kits (Immunotools, Friesoythe, Germany).

Phagocytosis assay {#sec2-5}
------------------

The cultured DCs was incubated with Af for 24 h (cell: Af = 1:10). Conidia that were not engulfed were counted using blood cell counting plate. The phagocytic rate was calculated as formula: (Total conidia--unengulfed conida)/Total conidia × 100%.

Western blot analysis for detection of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin {#sec2-6}
---------------------------------------------------------------------------------------------------------------------

The DCs were washed with phosphate-buffered saline and were lysed with radioimmunoprecipitation assay (RIPA) buffer. The protein concentration was measured, and 50 μg of total protein was used for electrophoresis. The Western blot analysis was performed under wet conditions at 240 mA for 2 h. Polyvinylidene difluoride (PVDF) membrane (Milipore, USA) was blocked with Tris Buffered Saline with Tween^®^ 20 (TBST) buffer containing 5% skimmed milk powder with shaking for 2 h and incubated with primary antibodies (DC-SIGN antibody; R&D, USA). Then, it was incubated with the second antibody for 1 h. The PVDF membrane was washed with TBST and developed with the eSports Champion League substrate. Software Quantity One was used to calculate the ratio of the gray level of the objective strap to the internal reference strap.

Construction of pDC316-mCMV-EGFP-dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin {#sec2-7}
---------------------------------------------------------------------------------------------------------------

DC-SIGN recombinant plasmid VRC4409-DC-SIGN was provided by Barney S. Graham (Viral Pathogenesis Laboratory, NIH, USA). DC-SIGN gene was amplified by polymerase chain reaction (PCR) with the primers: forward, 5'-ATAAGAATGCGGCCGCATGAGTGACTCCAAG-3', and reverse, 5'-CCCAAGCTTCTACGCAGGAGGGGG-3', and following reaction condition: 95°C, 5 min--95°C, 30 s--58°C, 40 s--72°C, 30 s for 30 cycles, and then 72°C, 7 min. Restriction enzyme NotI and HindIII (Takara, Japan) were used to digest the amplified DC-SIGN product and pDC316-mCMV-EGFP plasmid. Both products were harvested by gel extraction kit (QIAGEN, Germany) and linked by T4 DNA ligase (TaKaRa, Japan). DH5α competent cells (Tiangen Company, China) were transfected by the product. The recombinant plasmid was extracted from the *Escherichia coli* by plasmid extraction kit (QIAGEN, Germany). The DC-SIGN gene in recombinant pDC-mCMV-EGFP-DC-SIGN was identified by restriction enzyme digestion and electrophoresis.

Generation of recombinant adenovirus {#sec2-8}
------------------------------------

The 293 cells (Microbix Biosystems, Canada) were transfected with pDC-mCMV-EGFP-DC-SIGN and helper plasmid PPE3 by lipofectamine 2000 (Invitrogen) for 9--14 days to obtain adenovirus vector encoding DC-SIGN. After repeated filtering, the adenovirus vectors were purified. DC-SIGN gene in recombinant adenovirus DNA was extracted by the QIAGEN DNA Blood Mini kit (QIAGEN, USA) and confirmed by PCR with the primers DC-SIGN-F and DC-SIGN-R. The amplified virus titer was analyzed by TCID50. In the meanwhile, AdNull adenovirus without target gene inserted was generated in the same way.

T cells proliferation assay {#sec2-9}
---------------------------

The capacity of DCs to stimulate T cells proliferation was detected by allogeneic mixed lymphocyte reaction (MLR). T cells from PBMCs were purified through the nylon wool column: PBMCs were incubated at 37°C for 3 h and then nonadherent cells were collected. Before use, the column was equilibrated by washing with 20 ml RPMI-1640 and 10% FBS. Cells subjected to nylon wool purification were resuspended in 2 ml of RPMI-1640-10% FBS, and loaded onto the column. The column was sealed with 2 ml RPMI-1640 and incubated at 37°C for 60 min. Cells were eluted and plated at the concentration of 5 × 10^5^/ml.\[[@ref22]\] On the other hand, IFN-γ and Dex stimulated DCs were incubated with Mitomycin C on day 7 at 37°C for 45 min and resuspended by RPMI-1640 at the concentration of 5 × 10^4^/ml. The 0.1 ml purified T cells and 0.1 ml DCs were put in culture in 96-well plate for 72 h and then, 20 μl CCK8 was added into each well. The MLR assays were carried out by calculating the stimulation index with optical density value.

Ad-dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin transfected dendritic cells {#sec2-10}
-------------------------------------------------------------------------------------------------------------

MDDCs on day 4 were harvested and transfected with Ad-DC-SIGN or control vector AdNull (multiplicity of infection = 200) for 48 h in RPMI-1640 medium, supplied with 10% FBS, GM-CSF and IL-4. The treated cells were divided into Ad-DC-SIGN and AdNull groups. On day 7, the cells were incubated with the inactivated Af (DC:Af = 1:10) for 24 h, divided into Ad-DC-SIGN/Af group and AdNull/Af group.

Nuclear factor-κB activation assay {#sec2-11}
----------------------------------

Nuclear extracts from the treated DCs were obtained by human protein extraction kit (Biovision, USA). RIPA cell lysis buffer was used for extraction of cellular protein. The concentration of total protein and nuclear protein was measured by bicinchoninc acid protein assay. The expression of total NF-κBp65 and activated pho-NF-κBp65 which were transported to the nuclei were analyzed by the Western blot analysis.

Statistical analysis {#sec2-12}
--------------------

Statistical analysis was performed using SPSS version 24.0 (IBM, Chicago, IL, USA). The data were presented as mean ± standard deviation (SD). The unpaired, two-tailed Student\'s *t*-test was used in the comparisons between two groups. A *P* \< 0.05 was considered statistically significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Expression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin of interferon-γ/dexamethasone stimulated dendritic cells {#sec2-13}
-----------------------------------------------------------------------------------------------------------------------------------------------------

The DC-SIGN expression level in IFN-γ group decreased, compared to control group (0.894 ± 0.026 vs. 1.058 ± 0.041, *t* = 5.333, *P* \< 0.001). Compared to control/Af group (1.112 ± 0.053), the DC-SIGN expression in IFN-γ/Af (1.256 ± 0.119, *t* = 2.710, *P* = 0.030) and Dex/Af groups (1.207 ± 0.065, *t* = 2.752, *P* = 0.020) were much higher \[[Figure 1a](#F1){ref-type="fig"}\].

![The expression of DC-SIGN by Western blotting analysis (*n* = 6 in each group; a). The ability of DC stimulating T cells proliferation (b). \**P* \< 0.05 versus the same group cells without Af; ^†^*P* \< 0.05 versus control without Af (b). DC: Dendritic cell; Af: *Aspergillus fumigates*.](CMJ-131-2575-g001){#F1}

Interferon-γ/dexamethasone affected the dendritic cells capacity in stimulating T cells proliferation and phagocytosis {#sec2-14}
----------------------------------------------------------------------------------------------------------------------

We performed DCs capacity in stimulating T cells proliferation. There was no difference after IFN-γ or Dex treatment on DCs (control group: 2.03 ± 0.32; Dex group: 2.25 ± 0.02; IFN-γ group: 2.12: ± 0.36; *t*~(control\ vs.\ Dex)~= 1.682, *P*~(control\ vs\ Dex)~= 0.123; and *t*~(control\ vs.\ IFN-~γ~)~= 0.458, *P*~(control\ vs.\ IFN-~γ~)~= 0.657). After infected by Af, the DCs capacity in stimulating T-cell proliferation was significantly increased in control/Af group (2.96 ± 0.32), compared to control group (2.03 ± 0.32, *t* = 5.034, *P* = 0.001). In addition, there were significant differences in stimulating T-cell proliferation between IFN-γ/Af and IFN-γ groups (IFN-γ/Af: 2.66 ± 0.06, *t* = 3.624, *P* = 0.014), Dex/Af and Dex groups (Dex/Af: 3.55 ± 0.43, *t* = 7.401, *P* = 0.001). After Dex treatment, DCs with Af showed increasing capacity in stimulating T-cell proliferation compared to control/Af group (*t* = 2.696, *P* = 0.020). However, there was no significant difference among IFN-γ/Af and control/Af groups (*t* = 2.257, *P* = 0.070). The results suggested that stimulation with Dex could promote DCs capability in stimulating T-cell proliferation \[[Figure 1b](#F1){ref-type="fig"}\].

Dex treatment enhanced phagocytic activity of DCs following aspergillus conidia infection, compared to the control group (phagocytosis rates: 91.0% ± 3.4% in Dex group; 67.1% ± 10.1% in the control group, *t* = 5.493, *P* = 0.001); whereas IFN-γ did not enhance phagocytic activity of DCs following aspergillus conidia infection (phagocytosis rate in IFN-γ group: 66.7% ± 5.9%, *t* = 0.084, *P* = 0.935). It suggested that the inflammatory environment did not change DCs' capacity of phagocytosis and stimulating T cells proliferation. However, DCs from patients administered with immunosuppressant have enhanced phagocytosis.

Interferon-γ and dexamethasone affected Th1 and Th2 cytokine expression {#sec2-15}
-----------------------------------------------------------------------

**Interferon-γ and dexamethasone increased interleukin-12 expression of dendritic cells**

Compared to control group (20.98 ± 1.08 pg/ml), IL-12 expression level of DCs was significantly increased in IFN-γ (29.70 ± 2.68 pg/ml, *t* = 7.392, *P* \< 0.001) and Dex groups (41.61 ± 2.88 pg/ml, *t* = 16.429, *P* \< 0.001). Compared to control/Af group (29.70 ± 2.00 pg/ml), the IL-12 levels in IFN-γ/Af (50.96 ± 4.38 pg/ml, *t* = 10.815, *P* \< 0.001) and Dex/Af groups (41.18 ± 1.84 pg/ml, *t* = 10.347, *P* \< 0.001) were increased. The IL-12 level in control/Af group was also increased, compared to control group (*t* = 9.397, *P* \< 0.001; [Figure 2a](#F2){ref-type="fig"}).

![IFN-γ group and Dex affected Th1 and Th2 cytokines secretion from DCs: IL-12 (a) and IL-10 (b) secretion from DCs. Th1 and Th2 cytokines secretion from Ad-DC-SIGN transfected DCs: IL-12 (c) and IL-10 (d) secretion from DCs. \**P* \< 0.05 versus control group; ^†^*P* \< 0.05 versus control/Af group. DC: Dendritic cell; Af: *Aspergillus fumigates*; Dex: Dexamethasone; INF: Interferon; IL: Interleukin.](CMJ-131-2575-g002){#F2}

**Interferon-γ and dexamethasone decreased interleukin-10 expression of the *Aspergillus fumigatus* stimulated dendritic cells**

There was no significant difference in IL-10 expression between IFN-γ (20.80 ± 2.12 pg/ml) and control group (22.07 ± 4.32 pg/ml, *t* = 0.646, *P* = 0.533). Dex suppressed IL-10 expression compared to control group (dex group: 5.78 ± 1.40 pg/ml, *t* = 8.787, *P* \< 0.001). Compared to the control/Af group (15.14 ± 1.40 pg/ml), IL-10 levels in IFN-γ/Af (4.70 ± 1.45 pg/ml, *t* = 12.688, *P* \< 0.001) and Dex/Af (5.27 ± 0.85 pg/ml, *t* = 14.761, *P* \< 0.001) groups were significantly decreased. Stimulation with Af (control/Af group) could significantly decrease IL-10 expression compared to control group (*t* = 3.738, *P* = 0.010; [Figure 2b](#F2){ref-type="fig"}).

Dendritic cells over-expressed dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin after adenoviral vector-mediated gene delivery of dendritic cells-specific intercellular adhesion molecule-3-grabbing nonintegrin {#sec2-16}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ad-DC-SIGN was purified after propagation in 293 cells. The Ad-DC-SIGN DNA was isolated, and the *DC-SIGN* gene in the vector was identified by PCR analysis. A 1200 bp band was obtained that was specific for DC-SIGN insert gene \[[Figure 3a](#F3){ref-type="fig"}\], but the band was not observed in the empty vector AdNull. To detect vector transduction efficiency, the transfected DCs and 293 cells were observed under fluorescence microscope \[[Figure 3b](#F3){ref-type="fig"}\]. DC-SIGN of 293 cells and DCs were extracted for measurement of protein concentration by the Western blot analysis \[[Figure 3c](#F3){ref-type="fig"}\]. The results showed that the DC-SIGN modified 293 cells successfully expressed DC-SIGN protein, but DC-SIGN protein was not detected in naïve 293 cells or cells transfected with AdNull. Similarly, Ad-DC-SIGN transfected DCs expressed a higher level of DC-SIGN than the naïve cells or cells transfected with AdNull. The generated Ad-DC-SIGN can successfully express DC-SIGN in the target cells.

![The identification of recombinant adenovirus vector (a); The 293 cells and DC turned green after transfection with Ad-DC-SIGN under the fluorescence microscope (original magnification, × 200; b). Western blotting analysis of DC-SIGN protein fragment expressed in 293 cells and DCs (c). DC: Dendritic cell.](CMJ-131-2575-g003){#F3}

Higher expression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin modified dendritic cells and Mannan-stimulated dendritic cells {#sec2-17}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DCs were transfected with Ad-DC-SIGN and AdNull. Meanwhile, the Mannan was used to stimulate DCs. These three groups were Ad-DC-SIGN, AdNull, and Mannan. The expression level of DC-SIGN in DCs was analyzed before and after aspergillus infection. Ad-DC-SIGN and Mannan groups expressed higher levels of DC-SIGN than control group (Ad-DC-SIGN group: 1.306 ± 0.049; Mannan group: 1.520 ± 0.098; control group: 1.028 ± 0.023; *t*~(Ad-DC-SIGN\ vs.\ control)~= 12.515, *P*~(Ad-DC-SIGN\ vs.\ Control)~\<0.001; *t*~(Mannan\ vs.\ control)~= 11.948, *P*~(Mannan\ vs.\ control)~\<0.001). After aspergillus infection, there was no significant difference in the DC-SIGN level between Ad-DC-SIGN/Af and control/Af group (1.840 ± 0.054 vs. 1.833 ± 0.033 *t* = 0.253, *P* = 0.806), whereas Mannan/Af group (2.027 ± 0.025) showed higher DC-SIGN level than control/Af group (*t* = 11.585, *P* \< 0.001; [Figure 4](#F4){ref-type="fig"}).

![The analysis of DC-SIGN expressed in DC-SIGN modified DCs and mannan-stimulated DCs: Western blotting film and the ratio of DC-SIGN/β-actin. \**P* \< 0.05 versus control group; ^†^*P* \< 0.05 versus control/Af group. DC: Dendritic cell.](CMJ-131-2575-g004){#F4}

Capacity of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin modified dendritic cells in phagocytosis and stimulating T cells proliferation {#sec2-18}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Phagocytic function of DC-SIGN modified DCs was enhanced, compared with the control group (phagocytosis rates: 74.0% ± 3.4% in DC-SIGN modified DCs; 64.7% ± 6.8% in control group, *t* = 3.104, *P* = 0.013). However, the effects were reversed when DCs were stimulated by Mannan (phagocytosis rate: 44.1% ± 0.1% in mannan stimulated DCs, *t* = 7.420, *P* = 0.001).

The DCs function in promoting T cells proliferation did not significantly change among Ad-DC-SIGN/Af, AdNull/Af and control/Af groups. It indicated that DCs capacity in promoting T cells proliferation was not apparently affected by DC-SIGN gene over-expression.

Over-expression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in *Asepergillus fumigatus*-infected dendritic cells increased Th1 cytokine interleukin-12 {#sec2-19}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

There was no significant difference in IL-12 expression between Ad-DC-SIGN and control group (27.78 ± 11.96 pg/ml vs. 21.32 ± 4.90 pg/ml, *t* = 1.224, *P* = 0.263). Mannan group secreted more IL-12 than control group (Mannan group: 176.48 ± 51.07 pg/ml, *t* = 7.408, *P* = 0.001). After infection with Af, Ad-DC-SIGN/Af group secreted 14-fold more amount of IL-12 than control/Af group (471.98 ± 166.31 pg/ml vs. 33.35 ± 5.98 pg/ml; *t* = 6.456, *P* = 0.001). In addition, the Mannan/Af group also secreted a slightly more IL-12 than control/Af group (Mannan/Af: 107.9 ± 32.47 pg/ml, *t* = 5.531, *P* = 0.002; [Figure 2c](#F2){ref-type="fig"}).

Overexpression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in *Asepergillus fumigatus*-infected dendritic cells altered Th2 cytokine interleukin-10 expression {#sec2-20}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ad-DC-SIGN group secreted less IL-10 than control group (10.34 ± 3.65 pg/ml vs. 19.90 ± 5.12 pg/ml, *t* = 3.724, *P* = 0.004), indicating that Th2 cytokine expression was suppressed. After infection with Af, Ad-DC-SIGN/Af group secreted more IL-10 than control/Af group (Ad-DC-SIGN/Af group: 24.13 ± 4.69 pg/ml; control/Af group: 14.61 ± 2.14 pg/ml; *t* = 4.523, *P* = 0.003). In addition, Mannan/Af group secreted more IL-10 than control/Af group (Mannan/Af group: 30.17 ± 8.94 pg/ml; *t* = 4.146, *P* = 0.007), suggesting that Mannan and overexpression of DC-SIGN could promote secretion of IL-10 from Af-infected DCs \[[Figure 2d](#F2){ref-type="fig"}\].

Nuclear factor-κB was activated in Ad-dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin transfected dendritic cells after infection with aspergillus {#sec2-21}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The expression of pho-NF-κB p65 was analyzed usng the Western blot analysis. The results showed that overexpression of DC-SIGN in Ad-DC-SIGN transfected DCs could stimulate NF-κB to transport into nuclei and activate in the Ad-DC-SIGN transfected DCs with and without infection with Af. In addition, Mannan-stimulated DCs could not activate NF-κB \[[Figure 5](#F5){ref-type="fig"}\]. The results indicated that DC-SIGN was closely related to NF-κB signaling pathway.

![The activation of NF-κB in the DC-SIGN modified DC. DC: Dendritic cell; NF-κB: Nuclear factor-κB.](CMJ-131-2575-g005){#F5}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

DCs play an important role in immunity against aspergillosis and exert anti-aspergillus infection through multiple important signaling pathways.\[[@ref8]\] Recent studies have shown that DC-SIGN was closely related to intracellular signaling in DCs after aspergillus infection.\[[@ref7]\] In this study, the role of DC-SIGN in the processing of DC antigen presentation and T cells activation was investigated. We hypothesized that over-expression of DC-SIGN might has protective function on aspergillosis.

In this study, a large amount of immature DCs after stimulation with GM-CSF and IL-4 were successfully obtained. The immature DCs had strong antigen recognition ability. After antigen uptake, DCs became mature and showed an efficient ability in antigen processing and activating T cells.\[[@ref23]\]

IFN-γ and Dex were used to stimulate immature DCs. DCs of IFN-γ/Af group secreted more IL-12 and less IL-10, inducing immune response toward Th1 profile, which was consistent with the previous study.\[[@ref24]\] Dex group showed greater phagocytosis ability. However, there was little change in the expression level of IL-12 and IL-10 before and after stimulation with Af, suggesting that glucocorticoid could inhibit DCs activation. The results were in line with the previous report on Dectin-1, showing that glucocorticoid could interfere with DCs activation and function.\[[@ref25]\] DC-SIGN might participate in immune tolerance induced by Dex. However, it was paradoxical that DCs in Dex group secreted less amount of IL-10, which should be further investigated and discussed. In addition, this study also concluded that inflammatory (IFN-γ) or immunosuppressed (Dex) factor could not affect the capacity of DCs in stimulating T cells proliferation. The underlying mechanisms might be complicated and further comprehensive study should be performed.

It was well documented that the activated DCs secreted more Th1 cytokines and polarized the immune response toward a protective Th1 profile against fungal infection.\[[@ref6]\] DC vaccine could improve the efficiency of antigen presentation, so it has been widely used in animal models and human subjects. In our following experiment, we induced over-expression of DC-SIGN on DCs through adenoviral vector-mediated gene delivery of the DC-SIGN gene. Our results *in vitro* revealed the beneficial effects of DC-SIGN overexpression on DCs activation, as evidenced by the elevated expression level of Th1 cytokine IL-12 and phagocytosis of aspergillus.

This study used adenovirus as a vector for DC-SIGN gene delivery into DCs. DC-SIGN modified DCs could overexpression DC-SIGN, which was confirmed by quantitative reverse transcriptase-PCR, Western blot analysis, and fluorescent staining. Mannan was used to interfere with the binding of Af with DC-SIGN. The results showed that Mannan group had less phagocytosis of Af, but the Mannan/Af group expressed less amount of IL-12 than Ad-DC-SIGN/Af group. The results indicated that DC-SIGN recognized aspergillus conidia and participated in the immune response. The results of this study *in vitro* showed that the DC-SIGN modified DCs could highly express DC-SIGN and secret greater amount of IL-12 (471.98 ± 166.31 pg/ml) after infection with Af. Furthermore, the DC-SIGN modified DCs secreted more IL-10 than control/Af group; IL-10 expression remained at a relative low level (24.13 ± 4.69 pg/ml). The DC-SIGN over-expressing DCs could promote immune response toward Th1 profile and exert potent immune responses against aspergillosis. Mannan-stimulated DCs had similar effects as Ad-DC-SIGN transfected DCs. The elevated cytokine expression might be mediated by increased crosstalk between TLR and CLR.\[[@ref26][@ref27]\]

In addition, this study did not observe significant effects of DC-SIGN modified DCs on T cells proliferation, suggesting that DCs stimulating T-cell proliferation and phagocytosis might be mediated through different molecular mechanisms. As previously reported, DC-SIGN had various functions, positively or negatively regulating immune responses against aspergillus infection.\[[@ref28]\] After DC-SIGN modified DCs were infected with Aspergillus, NF-κB was activated and led to the elevation of pro-inflammatory cytokine production. Thus, we confirmed that high expression of DC-SIGN could promote immune responses against aspergillus infection through the NF-κB signaling pathway.

The findings of this study confirmed that DC-SIGN signaling pathway was one of the mechanisms involved in immune response against aspergillosis. DC-SIGN might participate in immune tolerance of aspergillus. However, the crude preps of Af were used for cell stimulation in this study, so the antigens or epitopes of Af might activate other signaling pathways. In addition, the cultured DCs might be contaminated with other cell types, such monocytes, etc. The factors possibly affected the results of this study. Due to the limitations of our experimental system, it was difficult to determine the antigen-specific T-cell priming and memory T-cell development. Further study should be performed to support the findings of this study regarding the effects of DC-SIGN in DCs.
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